Treatment recommendations include medications and lifestyle modification
Current guidelines for patients with chronic kidney disease and type 2 diabetes recommend treatments to address haemodynamic and metabolic factors, alongside lifestyle changes1,2

Comprehensive care in patients with diabetes and CKD. Kidney Disease: Improving Global Outcomes (KDIGO) 2020 treatment recommendations for patients with chronic kidney disease and type 2 diabetes1
RAS, renin–angiotensin system; SGLT2, sodium-glucose co-transporter-2
Reproduced from Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2020;98(4S):S1–S115. Copyright © 2020, KDIGO with permission from Elsevier

Recommended lifestyle modifications for patients with chronic kidney disease and type 2 diabetes2
American Diabetes Association. Diabetes Care 2020;43(suppl 1):S48–S65
1. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2020;98(4S):S1–S115.
2. American Diabetes Association. Diabetes Care 2020;43(suppl 1):S48–S65
MA-M_FIN-ALL-0200-1